MedTrace Logo

Low Dose of Norepinephrine Within 24-Hour Mortality in Traumatic Patient With Hemorrhagic Shock

NCT07053163 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-07-11

No results posted yet for this study

Summary

The aim of the work is to evaluate role of low dose of nor epinephrine administration in the early 24-hour period among traumatic patients and hemorrhagic shock. The primary outcome: evaluate mortality at first 24 hour. The secondary outcome : measure total fluid intake, observe renal functions and Hemodynamic changes.

Conditions

  • Mortality Rate
  • Hemorrhagic Shock

Interventions

DRUG

Crystalloid and blood as resuscitation

Patients receive crystalloid and blood as resuscitation

DRUG

crystalloid, blood and low dose of norepinephrine

Group 2: receive crystalloid, blood and low dose of norepinephrine

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Radwa Abdeldayem, Resident · Tanta University

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-30
Primary Completion
2024-08-30
Completion
2024-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07053163 on ClinicalTrials.gov